The Role of Drug Therapy in Lowering Mortality and Morbidity: From Established Heart Failure to High-Risk Hypertension
N Mistry, SE Kjeldsen, A Westheim - Hypertension and Heart Failure …, 2019 - Springer
… study where patients with post-myocardial infarction heart failure … In this study valsartan
significantly improved left ventricular … use of beta-blockers in the treatment of heart failure with left …
significantly improved left ventricular … use of beta-blockers in the treatment of heart failure with left …
The relevance of microRNA in post-infarction left ventricular remodelling and heart failure
M Dutka, R Bobiński, J Korbecki - Heart failure reviews, 2019 - Springer
… It has been shown that higher post-myocardial infarction mortality in patients with high …
infarction in rats, showed that the use of atorvastatin and valsartan after a myocardial infarction …
infarction in rats, showed that the use of atorvastatin and valsartan after a myocardial infarction …
Post-infarction heart failure-a multidimensional approach to the patient.
PM Jakubowska, I Bieniek… - Long-Term Care …, 2023 - search.ebscohost.com
… In the post-myocardial infarction chronic heart failure (… ) or a combination of sacubitril
and valsartan (in patients intolerant to the … of patients with heart failure, including post-myocardial …
and valsartan (in patients intolerant to the … of patients with heart failure, including post-myocardial …
… β-blocker use and mortality/morbidity in patients with heart failure with reduced, midrange, and preserved ejection fraction and advanced chronic kidney disease
… β-blocker use should be considered in all patients with HF … treatment of acute and chronic
heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of …
heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of …
Sex differences in heart failure hospitalisation risk following acute myocardial infarction
S Yandrapalli, A Malik, G Pemmasani, W Aronow… - Heart, 2021 - heart.bmj.com
… If you wish to reuse any or all of this article please use the link … , infarct size and post-myocardial
infarction cardiac function, … infarction: insights from the Valsartan in Acute Myocardial …
infarction cardiac function, … infarction: insights from the Valsartan in Acute Myocardial …
[引用][C] The Impact of SGLT2 Inhibitors in Post-Myocardial Infarction Management: Insights from EMPACT-MI and DAPA-MI Trials
ET Kato, K Hasegawa, K Ono - 2024 - academic.oup.com
… administration in AMI patients is reassuring and may support its use in this population, …
Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular …
Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular …
A year in heart failure: an update of recent findings
… was observed in patients receiving sacubitril/valsartan, albeit … -HF), the use of intravenous
FCM in patients hospitalized for … limited post-myocardial infarction (MI) cardiac remodelling. …
FCM in patients hospitalized for … limited post-myocardial infarction (MI) cardiac remodelling. …
Neprilysin inhibitors in heart failure: the science, mechanism of action, clinical studies, and unanswered questions
B Bozkurt, AP Nair, A Misra, CZ Scott, JH Mahar… - Basic to Translational …, 2023 - jacc.org
… peptides or among post-myocardial infarction patients in the … and morbidity in the The
Valsartan Heart Failure Trial, it did not … This study uses a battery of validated neurocognitive …
Valsartan Heart Failure Trial, it did not … This study uses a battery of validated neurocognitive …
Sacubitril-Valsartan (LCZ696) in the Treatment of Systemic Hypertension: An Updated Review of Neprilysin Inhibition Combined with Angiotensin II Receptor …
ME Katz, WH Frishman, WS Aronow - Cardiology in Review, 2024 - journals.lww.com
… When used in combination with valsartan, an ARB that attenuates the effects of the RAAS …
outcomes in heart failure, hypertension, renal disease, and the postmyocardial infarction state. …
outcomes in heart failure, hypertension, renal disease, and the postmyocardial infarction state. …
Reducing cardiac injury during ST-elevation myocardial infarction: a reasoned approach to a multitarget therapeutic strategy
A Bellis, G Di Gioia, C Mauro, C Mancusi… - Journal of Clinical …, 2021 - mdpi.com
… risk of arrhythmias and heart failure. Single pharmacological and … and mechanical intervention
application, according to their … demonstrated that treatment with valsartan can decrease …
application, according to their … demonstrated that treatment with valsartan can decrease …